SIM
GSK icon

Sonora Investment Management’s GSK GSK Stock Holding History

Sonora Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$56K Buy
1,178
+280
+31% +$14.1K 0.01% 395
2021
Q2 		$45K Buy
898
+480
+115% +$23.1K 0.01% 412
2021
Q1 		$19K Sell
418
-4,032
-91% -$183K ﹤0.01% 1009
2020
Q4 		$205K Buy
4,450
+3,664
+466% +$168K 0.02% 293
2020
Q3 		$37K Sell
786
-221
-22% -$11.1K ﹤0.01% 672
2020
Q2 		$51K Buy
1,007
+228
+29% +$11.7K 0.01% 512
2020
Q1 		$37K Hold
779
– – ﹤0.01% 571
2019
Q4 		$46K Buy
779
+449
+136% +$25K ﹤0.01% 576
2019
Q3 		$18K Buy
330
+103
+45% +$5.3K ﹤0.01% 915
2019
Q2 		$11K Hold
227
– – ﹤0.01% 1105
2019
Q1 		$12K Buy
227
+99
+77% +$4.95K ﹤0.01% 947
2018
Q4 		$6K Buy
128
+72
+129% +$3.55K ﹤0.01% 984
2018
Q3 		$3K Sell
56
-164
-75% -$8.33K ﹤0.01% 1083
2018
Q2 		$11K Buy
220
+44
+25% +$2.22K ﹤0.01% 755
2018
Q1 		$8.6K Sell
176
-24
-12% -$1.12K ﹤0.01% 837
2017
Q4 		$8.87K Buy
200
+80
+67% +$3.7K ﹤0.01% 837
2017
Q3 		$6.09K Buy
+120
New +$6.09K ﹤0.01% 821
2015
Q4 		– Sell
-224
Closed -$11K – 936
2015
Q3 		$11K Buy
+224
New +$11.7K ﹤0.01% 460

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sonora Investment Management's GSK Position: Q3 2021 in Review

Sonora Investment Management increased its GSK (GSK) stake by 31% in Q3 2021, buying an estimated $14.1K and bringing the position to 1,178 shares worth $56K. The position accounts for 0.01% of the portfolio, ranked #395.

Sonora Investment Management first reported a position in GSK in Q3 2015 and has held it in 18 quarters since. The position peaked at $205K in Q4 2020. 793 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • Sonora Investment Management held 1,178 shares of GSK worth $56K as of Q3 2021.
  • Sonora Investment Management bought 280 GSK shares in Q3 2021, an estimated $14.1K.
  • GSK made up 0.01% of Sonora Investment Management's portfolio in Q3 2021, its #395 holding.
  • Sonora Investment Management first reported a position in GSK in Q3 2015 and has held it in 18 quarters since.
  • Sonora Investment Management's GSK position peaked at $205K in Q4 2020.
  • 793 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.